DC-SIGN (CD209) promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation

PLoS Neglected Tropical Diseases

Volumn 5, Issue 1, 2011, Pages

  Wang, Lin ^a,c   Chen, Rong Fu ^a   Liu, Jien Wei ^a   Lee, Ing Kit ^a   Lee, Chiu Ping ^a   Kuo, Ho Chang ^a,c   Huang, Shau Ku ^b   Yang, Kuender D ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD209 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCINE; INTERLEUKIN 12P40; TUMOR NECROSIS FACTOR ALPHA; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CXCL10 PROTEIN, HUMAN; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN;

ADULT; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DENGUE; DENGUE VIRUS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MALE; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; VALIDATION PROCESS; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ADULT; CELL ADHESION MOLECULES; CELLS, CULTURED; CHEMOKINE CXCL10; DENDRITIC CELLS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; LECTINS, C-TYPE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 79851480892     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000934     Document Type: Article

References (41)

1. Wilder-Smith A, Schwartz E, (2005) Dengue in travelers. N Engl J Med 353: 924-932.
2. Pang T, Cardosa MJ, Guzman MG, (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85: 43-45.
3. Clyde K, Kyle JL, Harris E, (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80: 11418-11431.
4. Kimbrell DA, Beutler B, (2001) The evolution and genetics of innate immunity. Nat Rev Genet 2: 256-267.
5. Lee MS, Kim YJ, (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76: 447-480.
6. Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, et al. (2006) DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 176: 1741-1749.
7. Cambi A, Gijzen K, de Vries JM, Torensma R, Joosten B, et al. (2003) The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 33: 532-538.
8. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, et al. (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197: 823-829.
9. Gijzen K, Tacken PJ, Zimmerman A, Joosten B, de Vries IJ, et al. (2007) Relevance of DC-SIGN in DC-induced T cell proliferation. J Leukoc Biol 81: 729-740.
10. Wethmar K, Helmus Y, Luhn K, Jones C, Laskowska A, et al. (2006) Migration of immature mouse DC across resting endothelium is mediated by ICAM-2 but independent of beta2-integrins and murine DC-SIGN homologues. Eur J Immunol 36: 2781-2794.
11. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, et al. (2000) DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 1: 353-357.
12. Geijtenbeek TB, van Vliet SJ, Engering A, t Hart BA, van Kooyk Y, (2004) Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 22: 33-54.
13. Zhou T, Chen Y, Hao L, Zhang Y, (2006) DC-SIGN and immunoregulation. Cell Mol Immunol 3: 279-283.
14. Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, et al. (2004) Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 78: 14053-14056.
15. Liu H, Hwangbo Y, Holte S, Lee J, Wang C, et al. (2004) Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J Infect Dis 190: 1055-1058.
16. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, et al. (2005) A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37: 507-513.
17. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al. (2006) Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3: e20.
18. Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, et al. (2008) CD209 genetic polymorphism and tuberculosis disease. PLoS One 3: e1388.
19. Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, et al. (2006) Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol 48: 84-90.
20. Chen RF, Yang KD, Wang L, Liu JW, Chiu CC, et al. (2007) Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg 101: 1106-1113.
21. Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, et al. (2005) Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 44: 43-50.
22. Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, et al. (2009) Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol 131: 404-409.
23. Wang L, Chen RF, Liu JW, Yu HR, Kuo HC, et al. (2007) Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. Am J Trop Med Hyg 77: 297-302.
24. Bandyopadhyay S, Lum LC, Kroeger A, (2006) Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 11: 1238-1255.
25. Baggiolini M, Dewald B, Moser B, (1997) Human chemokines: an update. Annu Rev Immunol 15: 675-705.
26. Nightingale ZD, Patkar C, Rothman AL, (2008) Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol 84: 1028-1038.
27. Palmer DR, Sun P, Celluzzi C, Bisbing J, Pang S, et al. (2005) Differential effects of dengue virus on infected and bystander dendritic cells. J Virol 79: 2432-2439.
28. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, et al. (2006) Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol 177: 3185-3192.
29. van Vliet SJ, Garcia-Vallejo JJ, van Kooyk Y, (2008) Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses. Immunol Cell Biol 86: 580-587.
30. Ryan EJ, Dring M, Ryan CM, McNulty C, Stevenson NJ, et al. (2010) Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection. Hum Immunol 71: 829-832.
31. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
32. Lee IK, Liu JW, Yang KD, (2008) Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. Am J Trop Med Hyg 79: 149-153.
33. Figueiredo MA, Rodrigues LC, Barreto ML, Lima JW, Costa MC, et al. (2010) Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis 4: e699.
34. Wichukchinda N, Kitamura Y, Rojanawiwat A, Nakayama EE, Song H, et al. (2007) The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses 23: 686-692.
35. Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, et al. (2005) Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem 280: 23698-23708.
36. Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, et al. (2004) Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol 78: 8322-8332.
37. van Kooyk Y, Geijtenbeek TB, (2003) DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3: 697-709.
38. Mukhopadhyay S, Kuhn RJ, Rossmann MG, (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13-22.
39. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9: 921-927.
40. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672-676.
41. Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, et al. (2006) Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 38: 38-46.